Viridian Therapeutics to participate in Wells Fargo healthcare conference fireside chat
Viridian Therapeutics (Nasdaq: VRDN) says senior management will take part in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference.
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced that senior management will participate in a fireside chat at the Wells Fargo 21st Annual…